Hepatitis C antivirals' most common adverse effect is anemia

04/29/2013 | MedPage Today (free registration)

An analysis of data from more than 1,400 patients in the U.S. found that anemia is the most reported side effect of two direct-acting antiviral drugs used to treat patients with the hepatitis C virus. Researchers found that more than 50% of the patients who took boceprevir or telaprevir experienced anemia. The findings were presented at a liver disease research meeting in Europe.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ